Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 12/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6423819 | 0.98 | SIGMAR1 (0.41) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL7590414 | 0.98 | SIGMAR1 (0.43) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL1494478 | 0.98 | SIGMAR1 (0.43) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| Hydrochloric Acid SCHEMBL28404227 | 0.96 | SIGMAR1 (0.42) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL1607970 | 0.92 | OPRD1 (0.41) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL29926143 | 0.85 | SIGMAR1 (0.47) | SIGMAR1SLC6A4SLC6A2CHRM3SLC6A3 | |
| SCHEMBL2910332 | 0.84 | OPRD1 (0.38) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL27667325 | 0.84 | SIGMAR1 (0.44) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL8310688 | 0.84 | SIGMAR1 (0.41) | SIGMAR1OPRD1OPRM1SLC6A4SLC6A2 | |
| SCHEMBL3102765 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4583926-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4511379-A2 | THERANOSTIC SILICON-FLUORIDE HETEROAROMATIC SYSTEMS AND METHODS THEREOF | Fuzionaire Theranostics, Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-2024052550-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4308551-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | Bayer Aktiengesellschaft (DE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023205755-A2 | THERANOSTIC SILICON-FLUORIDE HETEROAROMATIC SYSTEMS AND METHODS THEREOF | FUZIONAIRE DIAGNOSTICS, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| CN-115243729-A | Macrocyclic chelates and their use | 融合制药公司 | 2022-10-25 | — | — | CN | disclosed |
| WO-2022194777-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-22 | — | — | WO | disclosed |